Clinuvel Pharmaceuticals
CUV.AX
#7647
Rank
HK$2.73 B
Marketcap
HK$54.45
Share price
-1.97%
Change (1 day)
-3.20%
Change (1 year)

Earnings for Clinuvel Pharmaceuticals (CUV.AX)

Earnings in 2025: HK$0.26 Billion

According to Clinuvel Pharmaceuticals's latest financial reports the company's current earnings are HK$62.5 Million. In 2025 the company made an earning of HK$0.26 Billion, an increase over its 2024 earnings that were of HK$0.26 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clinuvel Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025HK$0.26 B0.26%
2024HK$0.26 B11.35%
2023HK$0.23 B28.31%
2022HK$0.18 B22.8%
2021HK$0.15 B112.63%
2020HK$70.96 M-28.73%
2019HK$99.58 M32.79%
2018HK$74.99 M75.41%
2017HK$42.75 M-332.52%
2016-HK$18.39 Million-70.68%
2015-HK$62.72 Million53.78%
2014-HK$40.79 Million-16.1%
2013-HK$48.61 Million-37.92%
2012-HK$78.31 Million-18.19%
2011-HK$95.72 Million25.31%
2010-HK$76.39 Million-21.53%
2009-HK$97.35 Million-11.27%
2008-HK$0.11 Billion80.4%
2007-HK$60.82 Million-2.46%
2006-HK$62.35 Million-5.35%
2005-HK$65.88 Million60.55%
2004-HK$41.03 Million97.37%
2003-HK$20.79 Million50.62%
2002-HK$13.81 Million121.22%
2001-HK$6.24 Million254.48%
2000-HK$1.77 Million